Seguir
MARIA DE LA ALMUDENA GOMEZ HERNANDEZ
MARIA DE LA ALMUDENA GOMEZ HERNANDEZ
Profesor Titular. Departamento de Bioquímica y Biología Molecular. Facultad de Farmacia. UCM
Dirección de correo verificada de ucm.es
Título
Citado por
Citado por
Año
Differential role of adipose tissues in obesity and related metabolic and vascular complications
A Gómez-Hernández, N Beneit, S Díaz-Castroverde, Ó Escribano
International journal of endocrinology 2016, 2016
2462016
Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells
MA Hernández-Presa, JL Martın-Ventura, M Ortego, A Gómez-Hernández, ...
Atherosclerosis 160 (1), 49-58, 2002
2082002
Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month
JL Martín-Ventura, LM Blanco-Colio, A Gómez-Hernández, ...
Stroke 36 (8), 1796-1800, 2005
1772005
Protective role of oleic acid against cardiovascular insulin resistance and in the early and late cellular atherosclerotic process
L Perdomo, N Beneit, YF Otero, Ó Escribano, S Díaz-Castroverde, ...
Cardiovascular diabetology 14, 1-12, 2015
1592015
Leukotriene B4 enhances the activity of nuclear factor-κB pathway through BLT1 and BLT2 receptors in atherosclerosis
E Sánchez-Galán, A Gómez-Hernández, C Vidal, JL Martín-Ventura, ...
Cardiovascular research 81 (1), 216-225, 2009
1552009
NF-κB activation and Fas ligand overexpression in blood and plaques of patients with carotid atherosclerosis: potential implication in plaque instability
JL Martín-Ventura, LM Blanco-Colio, B Muñoz-García, ...
Stroke 35 (2), 458-463, 2004
1382004
Overexpression of COX-2, prostaglandin E synthase-1 and prostaglandin E receptors in blood mononuclear cells and plaque of patients with carotid atherosclerosis: regulation by …
A Gómez-Hernández, JL Martín-Ventura, E Sánchez-Galán, C Vidal, ...
Atherosclerosis 187 (1), 139-149, 2006
1302006
Licofelone, a balanced inhibitor of cyclooxygenase and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis
C Vidal, A Gomez-Hernandez, E Sanchez-Galan, A Gonzalez, L Ortega, ...
Journal of Pharmacology and Experimental Therapeutics 320 (1), 108-116, 2007
922007
Licofelone, a balanced inhibitor of cyclooxygenase and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis
C Vidal, A Gomez-Hernandez, E Sanchez-Galan, A Gonzalez, L Ortega, ...
Journal of Pharmacology and Experimental Therapeutics 320 (1), 108-116, 2007
912007
β-Cell hyperplasia induced by hepatic insulin resistance: role of a liver-pancreas endocrine axis through insulin receptor A isoform
O Escribano, C Guillén, C Nevado, A Gomez-Hernández, CR Kahn, ...
Diabetes 58 (4), 820-828, 2009
892009
Updating experimental models of diabetic cardiomyopathy
J Fuentes-Antras, B Picatoste, A Gomez-Hernandez, J Egido, J Tunon, ...
Journal of diabetes research 2015, 2015
802015
The role of insulin receptor isoforms in diabetes and its metabolic and vascular complications
O Escribano, N Beneit, C Rubio-Longás, AR López-Pastor, ...
Journal of diabetes research 2017, 2017
732017
Atorvastatin reduces the expression of prostaglandin E2 receptors in human carotid atherosclerotic plaques and monocytic cells: potential implications for plaque stabilization
A Gómez-Hernández, E Sánchez-Galán, JL Martín-Ventura, C Vidal, ...
Journal of cardiovascular pharmacology 47 (1), 60-69, 2006
712006
HMG-CoA reductase inhibitors reduce IκB kinase activity induced by oxidative stress in monocytes and vascular smooth muscle cells
M Ortego, A Gómez-Hernández, C Vidal, E Sánchez-Galán, ...
Journal of cardiovascular pharmacology 45 (5), 468-475, 2005
542005
Chronic exercise improves mitochondrial function and insulin sensitivity in brown adipose tissue
N De las Heras, M Klett-Mingo, S Ballesteros, B Martín-Fernández, ...
Frontiers in physiology 9, 394824, 2018
482018
Expression of insulin receptor (IR) A and B isoforms, IGF-IR, and IR/IGF-IR hybrid receptors in vascular smooth muscle cells and their role in cell migration in atherosclerosis
N Beneit, CE Fernández-García, JL Martín-Ventura, L Perdomo, ...
Cardiovascular Diabetology 15, 1-14, 2016
392016
Brown fat lipoatrophy and increased visceral adiposity through a concerted adipocytokines overexpression induces vascular insulin resistance and dysfunction
A Gomez-Hernandez, YF Otero, N de las Heras, O Escribano, ...
Endocrinology 153 (3), 1242-1255, 2012
392012
Effect of intensive atorvastatin therapy on prostaglandin E2 levels and metalloproteinase-9 activity in the plasma of patients with non-ST-elevation acute coronary syndrome
A Gómez-Hernández, E Sánchez-Galán, M Ortego, JL Martín-Ventura, ...
The American journal of cardiology 102 (1), 12-18, 2008
362008
miRNA dysregulation in the development of non-alcoholic fatty liver disease and the related disorders type 2 diabetes mellitus and cardiovascular disease
AR López-Pastor, J Infante-Menéndez, Ó Escribano, ...
Frontiers in Medicine 7, 527059, 2020
332020
Factors involved in rosuvastatin induction of insulin sensitization in rats fed a high fat diet
N De las Heras, M Valero-Muñoz, S Ballesteros, A Gómez-Hernández, ...
Nutrition, metabolism and cardiovascular diseases 23 (11), 1107-1114, 2013
322013
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20